Mutant calreticulin for the diagnosis of myeloid malignancies Grant US-11274350-B2 United States of America 15 Mar 2022
ANTI-TRUNCATED MUTANT CALR-CD3 BISPECIFIC ANTIBODY AND PHARMACEUTICAL COMPOSITION Application WO-2022045247-A1 World Intellectual Property Organisation (WIPO) 03 Mar 2022
ANTIBODY CAPABLE OF BINDING TO TRUNCATED MUTANT CALRETICULIN, AND DIAGNOSTIC… Application WO-2020175689-A1 World Intellectual Property Organisation (WIPO) 03 Sep 2020
MULTIFUNCTIONAL MOLECULES THAT BIND TO CALRETICULIN AND USES THEREOF Application WO-2020172601-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020
MULTIFUNCTIONAL MOLECULES THAT BIND TO CALRETICULIN AND USES THEREOF Application WO-2019178362-A1 World Intellectual Property Organisation (WIPO) 19 Sep 2019
Mutant calreticulin for the diagnosis of myeloid malignancies Grant US-10344335-B2 United States of America 09 Jul 2019
VACCINE COMPOSITION COMPRISING MUTANT CALRETICULIN Application EP-3494985-A1 European Patent Office 12 Jun 2019
MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES Application EP-3020727-B1 European Patent Office 04 Apr 2018
ANTI-MUTANT CALRETICULIN ANTIBODIES AND THEIR USE IN THE DIAGNOSIS AND THERAPY OF MYELOID… Application WO-2016087514-A1 World Intellectual Property Organisation (WIPO) 09 Jun 2016